Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tema Oncology ETF
(NQ:
CANC
)
34.73
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
21
Open
34.73
Bid (Size)
13.90 (200)
Ask (Size)
55.56 (200)
Prev. Close
34.73
Today's Range
34.73 - 34.73
52wk Range
20.10 - 36.14
Shares Outstanding
N/A
Dividend Yield
2.10%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance
December 02, 2025
From
Tema ETFs
Via
Business Wire
AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK
↗
November 25, 2025
NICE has recommended that Aucatzyl be used as a treatment option for adult patients aged 26 years or older with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, the company said.
Via
Stocktwits
Performance
YTD
+42.1%
+42.1%
1 Month
+3.4%
+3.4%
3 Month
+27.8%
+27.8%
6 Month
+40.1%
+40.1%
1 Year
+36.8%
+36.8%
More News
Read More
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
↗
April 25, 2024
Via
Investor's Business Daily
Healthcare ETFs For The Weight-Loss Drug Boom And Beyond
↗
April 08, 2024
Via
Talk Markets
Topics
Artificial Intelligence
ETFs
Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too?
↗
December 05, 2023
Via
Benzinga
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
↗
December 01, 2023
Via
Benzinga
Topics
ETFs
Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction
↗
November 28, 2023
Via
Benzinga
Topics
ETFs
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
↗
November 21, 2023
Via
Benzinga
Topics
ETFs
Frequently Asked Questions
Is Tema Oncology ETF publicly traded?
Yes, Tema Oncology ETF is publicly traded.
What exchange does Tema Oncology ETF trade on?
Tema Oncology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Tema Oncology ETF?
The ticker symbol for Tema Oncology ETF is CANC on the Nasdaq Stock Market
What is the current price of Tema Oncology ETF?
The current price of Tema Oncology ETF is 34.73
When was Tema Oncology ETF last traded?
The last trade of Tema Oncology ETF was at 12/16/25 04:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today